|
Q3 FY2024
As of Sep 30, 2023
|
Q2 FY2024
As of Jun 30, 2023
|
Q1 FY2024
As of Mar 31, 2023
|
Q4 FY2023
As of Dec 31, 2022
|
Q3 FY2023
As of Sep 30, 2022
|
Q2 FY2023
As of Jun 30, 2022
|
Q1 FY2023
As of Mar 31, 2022
|
Q4 FY2022
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|
| Current assets | ||||||||
| Cash and cash equivalents | ||||||||
| Accounts receivable net of allowances of $322 in 2022 and $268 in 2021, respectively | ||||||||
| Restricted cash | ||||||||
| Accounts receivable net of allowances of $68 in 2023 and $322 in 2022 | ||||||||
| Inventory | ||||||||
| Deposits, prepaids and other current assets | ||||||||
| Investment in non-marketable securities | ||||||||
| Cost in excess of billings | ||||||||
| Investments in marketable securities | ||||||||
| Investments in non-marketable securities | ||||||||
| Contract assets | ||||||||
| Total current assets | ||||||||
| Property, plant and equipment, net | ||||||||
| Finance lease right-of-use assets | ||||||||
| Right-of-use asset | ||||||||
| Operating lease right-of-use asset | ||||||||
| Operating lease right-of-use assets | ||||||||
| Non-current assets | ||||||||
| Net deferred tax asset | ||||||||
| Goodwill | ||||||||
| Intangible assets, net | ||||||||
| Total Assets | ||||||||
| Current liabilities | ||||||||
| Accounts payable | ||||||||
| Accrued liabilities | ||||||||
| Contract liabilities | ||||||||
| Contract liabilities | ||||||||
| Derivative liability | ||||||||
| Convertible notes payable, net of discount | ||||||||
| Convertible notes payable, related party, net of discount | ||||||||
| Line of credit | ||||||||
| Related party payable | ||||||||
| Derivative liabilities | ||||||||
| Lease liability | ||||||||
| Finance lease liability | ||||||||
| Present value of lease liability | ||||||||
| Finance lease liabilities | ||||||||
| Operating lease liability | ||||||||
| Operating lease liabilities | ||||||||
| Current portion of long-term debt | ||||||||
| Total current liabilities | ||||||||
| Non-current liabilities | ||||||||
| Finance lease liabilities, non-current | ||||||||
| Lease liability, non-current | ||||||||
| Operating lease liability, non-current | ||||||||
| Notes payable, net of discount | ||||||||
| Convertible notes payable, net of discount | ||||||||
| Operating lease liabilities, non-current | ||||||||
| Long-term debt, net of current portion | ||||||||
| Contingent consideration liability | ||||||||
| Net deferred tax liability | ||||||||
| Total Liabilities | ||||||||
| Series C preferred stock (6,226,370 shares issued and outstanding at September 30, 2023, and December 31, 2022) | ||||||||
| Series C Preferred Stock | ||||||||
| Total series C preferred stock (6,226,370 shares issued and outstanding at September 30, 2023, and December 31, 2022) | ||||||||
| Total Mezzanine Equity | ||||||||
| Commitments, contingencies and concentration risk | ||||||||
| Stockholders' Equity | ||||||||
| Preferred stock | ||||||||
| Series A Preferred Stock | ||||||||
| Series B Preferred stock | ||||||||
| Series C Preferred Stock | ||||||||
| Series D Preferred Stock | ||||||||
| Series E Preferred Stock | ||||||||
| Total preferred stock | ||||||||
| Common stock, $0.0001 par value; 750,000,000 shares authorized, 215,039,868 and 206,844,580 issued and outstanding at September 30, 2023 and December 31, 2022, respectively | ||||||||
| Common stock to be issued, 6,587,897 and 13,425,596 shares at December 31, 2021 and 2020 | ||||||||
| Common Stock To Be Issued, 6,587,897 Shares At March 31, 2022 And December 31, 2021 | ||||||||
| Common stock to be issued, 0 shares at December 31, 2022 and 6,587,897 at December 31, 2021 | ||||||||
| Additional paid in capital | ||||||||
| Accumulated other comprehensive income (loss) | ||||||||
| Accumulated deficit | ||||||||
| Series B Preferred stock | ||||||||
| Series C Preferred Stock | ||||||||
| Total Stockholders' Equity | ||||||||
| Total Liabilities and Stockholders' Equity |
Loading...
